Arcturus Therapeutics Holdings Inc Environmental Analytics
Environmental and financial analysis dashboard for Arcturus Therapeutics Holdings Inc. Industry: PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES
Company Overview for Arcturus Therapeutics Holdings Inc
Highlights
Showing data for FY2022
Operational Environmental Cost
$2.18m
Operational Environmental Cost Intensity
1.11%
Total Environmental Cost
N/A
Total Environmental Cost Intensity
N/A
ΔOperational Environmental Cost (2020-2022)
$2.14m
Decoupling Rate (2020-2022)
-63%
Adjusted EBITDA
$12m
Adjusted EBITDA Margin
6.27%
Environmental cost statement
Showing data for FY2022
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| OPERATIONAL SOCIAL COST OF CARBON | ||||
| 55.05% | 1494.96% | -23.31% | ||
| 0.15% | 0.17% | 0.17% | 0.15% | |
| 173.92% | 2503.35% | -20.35% | ||
| 0.27% | 0.57% | 0.93% | 0.85% | |
| $0m | $0m | $2m | $2m | |
| 132.28% | 2267.58% | -20.81% | ||
| 0.42% | 0.75% | 1.11% | 1.01% | |
| INDIRECT SOCIAL COST OF CARBON | ||||
| N/A | N/A | N/A | ||
| N/A | N/A | N/A | N/A | |
| N/A | N/A | N/A | ||
| N/A | N/A | N/A | N/A | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. Scope 2: Social Cost of Carbon is calculated using market-based emissions data. | ||||
Environmental cost bridge
Showing data for FY2022
Integrated financial analysis
Highlights
Showing data for FY2022
Adjusted EBITDA Margin
6.27%
Adjusted EBIT Margin
5.52%
EV / Adjusted EBITDA
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
EV / Adjusted EBIT
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
Integrated income statement
Showing data for FY2022
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| INCOME STATEMENT | ||||
$10m | $12m | $197m | $171m | |
| 29.56% | 1491.26% | -12.92% | ||
$80m | $214m | $182m | $198m | |
| 838.39% | 1731.68% | 92.63% | 115.32% | |
$-70m | $-202m | $15m | $-26m | |
| -738.39% | -1631.68% | 7.37% | -15.32% | |
$-71m | $-203m | $13m | $-29m | |
| -747.64% | -1641.33% | 6.63% | -17.19% | |
| ENVIRONMENTAL COST DATA | ||||
$0m | $0m | $2m | $2m | |
| 0.42% | 0.75% | 1.11% | 1.01% | |
| FINANCIAL DATA ADJUSTED FOR OPERATIONAL ENVIRONMENTAL COST | ||||
$-70m | $-202m | $12m | $-28m | |
| -738.81% | -1632.42% | 6.27% | -16.33% | |
$-71m | $-203m | $11m | $-31m | |
| -748.05% | -1642.08% | 5.52% | -18.20% | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. | ||||
Environmental EBITDA bridge
Showing data for FY2022
Industry benchmark
RESEARCH AND EXPERIMENTAL DEVELOPMENT ON NATURAL SCIENCES AND ENGINEERING
Scope 1 (% of Sales)
0.17%
Scope 2 (% of Sales)
0.93%
Operational Environmental Cost Intensity
1.11%
Scope 3 (% of Sales)
N/A
Total Environmental Cost Intensity
N/A
Selected peer group
Showing data for FY2022
NAME | COUNTRY | OPERATIONAL ENV. COST | OPERATIONAL ENV. COST INTENSITY |
|---|---|---|---|
Arcturus Therapeutics Holdings Inc | US | $2m | 1.11% |
Loading similar companies data...
Industry distribution
Showing data for FY2022
Note: Outliers are calculated using the 1.5 * IQR method, where values outside Q1 - 1.5 * IQR and Q3 + 1.5 * IQR are considered outliers.
Estimated Social Cost of Carbon Scope 3 breakdown
Percentage breakdown of Social Cost of Carbon Scope 3 into various categories
Showing data for FY2022
SCOPE 3 CATEGORY | Company (USD) | Company % | Industry Avg (USD) | Industry Avg % |
|---|---|---|---|---|
Purchased goods (1 & 2) | N/A | N/A | N/A | N/A |
Energy-related activities (3) | N/A | N/A | N/A | N/A |
Upstream transportation (4) | N/A | N/A | N/A | N/A |
Waste (5) | N/A | N/A | N/A | N/A |
Business travel (6) | N/A | N/A | N/A | N/A |
Commuting (7) | N/A | N/A | N/A | N/A |
Upstream leased assets (8) | N/A | N/A | N/A | N/A |
Downstream transportation (9) | N/A | N/A | N/A | N/A |
Processing of products (10) | N/A | N/A | N/A | N/A |
Use of products (11) | N/A | N/A | N/A | N/A |
Final treatment of products (12) | N/A | N/A | N/A | N/A |
Downstream leased assets (13) | N/A | N/A | N/A | N/A |
Franchises (14) | N/A | N/A | N/A | N/A |
Investments (15) | N/A | N/A | N/A | N/A |
Total | $0m | 100.00% | $0m | 100.00% |
Scope 3 breakdown visualization
Showing data for FY2022